I1DX34:BVMF
Idexx Laboratories Inc Bdr
531,51 R$
0,00%
(0,00) 1D
14 ოქტ, 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for I1DX34...
Open
531,51 R$
High
531,51 R$
Low
531,51 R$
Mkt. cap
41,68 მლრდ.
Avg. vol.
6,00
Volume
1,00
52-wk high
813,60 R$
52-wk low
509,99 R$
Shares outstanding
78,78 მლნ.
No. of employees
11 ათ.
Open
531,51 R$
High
531,51 R$
Low
531,51 R$
Mkt. cap
41,68 მლრდ.
Avg. vol.
6,00
Volume
1,00
52-wk high
813,60 R$
52-wk low
509,99 R$
Shares outstanding
78,78 მლნ.
No. of employees
11 ათ.
News stories
From web sources and news partners
Yahoo Finance
·
4 საათის წინ
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts
Simply Wall Street
·
18 საათის წინ
IDEXX Laboratories (IDXX) Stock May Be 12% Undervalued Despite AI Acquisition
Investing.com
·
2 დღის წინ
KeyBanc initiates Idexx Laboratories stock rating at Sector Weight
Profile
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
About Idexx Laboratories Inc Bdr
CEOჯეი მაზელსკი
Employees11 ათ.
Founded19 დეკ. 1983
HeadquartersWestbrook, მენის შტატი, ამერიკის შეერთებული შტატები
SectorMedical device
Websiteidexx.com